Scale/Scope:
14 maternity clinics from greater Harare
Evaluation Design:
RCT – 437 HIV+ postintervention women from the ZVITAMBO clinical trial (20 received 3 visits, 108 received 2 visits, 234 received 1 visit, 75 received no visits); used data collected at 6 weeks postpartum, 3 months postpartum, and every 3 months thereafter for up to 24 months
Outcomes
Outcomes Measured:
% EBF at 6 weeks
Results:
Dose response: 0 vs. 1 vs. 2 vs. 3 visits: 8% vs. 15% vs. 14.8% vs. 30%
P-values/CIs:
p=0.02
High Impact Practices:
Exclusive breastfeeding
Outcomes Measured:
% EBF at 3 months
Results:
Dose response: 0 vs. 1 vs. 2 vs. 3 visits: 6.7% vs. 12.8% vs. 17.6% vs. 25%
P-values/CIs:
p=0.005
High Impact Practices:
Exclusive breastfeeding
Outcomes Measured:
% EBF at 6 months
Results:
Dose response: 0 vs. 1 vs. 2 vs. 3 visits: 4.0% vs. 6.0% vs. 4.6% vs. 5.0%
P-values/CIs:
p=0.48
High Impact Practices:
Exclusive breastfeeding